(NOVO-B) Novo Nordisk - Performance -46.2% in 12m
NOVO-B performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
47.08%
#12 in Peer-Group
Rel. Strength
11.82%
#6712 in Stock-Universe
Total Return 12m
-46.22%
#114 in Peer-Group
Total Return 5y
161.01%
#8 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 20.2 |
| P/E Forward | 17.7 |
| High / Low | DKK |
|---|---|
| 52 Week High | 1007.21 DKK |
| 52 Week Low | 390.00 DKK |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 91.66 |
| Buy/Sell Signal +-5 | -1.61 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: NOVO-B (-46.2%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
9.2% | 80.8% | 81.6% | 23 | 13.8 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-8.02% | -1.47% | 149% | 12.9 | 12 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
10.1% | 2.09% | 57% | 26.2 | 13.8 | 0.96 | 0.60% | 41% |
| BIM PA Biomerieux |
3.05% | 33.4% | 9.65% | 32.6 | 25.6 | 1.54 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
6.43% | -8.71% | 7.86% | 42.4 | 24.4 | 0.27 | 18.7% | -34.3% |
| PTCT NASDAQ PTC Therapeutics |
10.5% | 38.9% | 4.12% | 7.86 | 6.36 | 0.81 | - | 68% |
| KMDA NASDAQ Kamada |
-0.15% | 37.3% | -12% | 24.6 | 20.4 | 0.81 | 48.1% | 3.93% |
| ERF PA Eurofins Scientific SE |
9.39% | 16% | 11.2% | 28.1 | 14.3 | 0.59 | -62.1% | -19.3% |
Performance Comparison: NOVO-B vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for NOVO-B
| Total Return (including Dividends) | NOVO-B | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 17.69% | 7.80% | 1.73% |
| 3 Months | -0.03% | -2.75% | 8.59% |
| 12 Months | -46.22% | -10.76% | 11.46% |
| 5 Years | 161.01% | -18.55% | 109.12% |
| Trend Score (consistency of price movement) | NOVO-B | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 92.6% | 84.2% | 69.9% |
| 3 Months | -23.4% | -2.8% | 69.3% |
| 12 Months | -96.4% | -77.8% | 43.2% |
| 5 Years | 90.4% | -53.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #64 | 9.18% | 15.69% |
| 3 Month | #89 | 2.80% | -7.94% |
| 12 Month | #113 | -39.74% | -51.75% |
| 5 Years | #8 | 220.46% | 24.82% |
FAQs
Does Novo Nordisk (NOVO-B) outperform the market?
No,
over the last 12 months NOVO-B made -46.22%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.76%.
Over the last 3 months NOVO-B made -0.03%, while XBI made -2.75%.
Performance Comparison NOVO-B vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
NOVO-B vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 5.6% | 16% | -29.8% | -58% |
| US NASDAQ 100 | QQQ | 5.8% | 15.5% | -30% | -57% |
| German DAX 40 | DAX | 8.5% | 18.3% | -45.2% | -74% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 5.6% | 18.6% | -30.3% | -59% |
| Hongkong Hang Seng | HSI | 4.3% | 12% | -46.7% | -73% |
| India NIFTY 50 | INDA | 6.9% | 17.6% | -28.4% | -46% |
| Brasil Bovespa | EWZ | 3.8% | 18.4% | -47% | -54% |
NOVO-B vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 6.4% | 15.3% | -32.6% | -70% |
| Consumer Discretionary | XLY | 5.5% | 19.3% | -20.7% | -65% |
| Consumer Staples | XLP | 6.2% | 16.4% | -30.4% | -54% |
| Energy | XLE | -0.4% | 15% | -30.7% | -49% |
| Financial | XLF | 7.8% | 19.9% | -32% | -71% |
| Health Care | XLV | 4% | 14.5% | -27.8% | -41% |
| Industrial | XLI | 6.8% | 16.7% | -35% | -65% |
| Materials | XLB | 5.7% | 16.2% | -29.3% | -45% |
| Real Estate | XLRE | 5.3% | 15.7% | -29.9% | -59% |
| Technology | XLK | 4.9% | 14.9% | -30.8% | -52% |
| Utilities | XLU | 5% | 15.5% | -36.9% | -66% |
| Aerospace & Defense | XAR | 5.5% | 9.6% | -48.5% | -88% |
| Biotech | XBI | 6.1% | 9.9% | -19.9% | -35% |
| Homebuilder | XHB | 6.2% | 24.6% | -13.2% | -36% |
| Retail | XRT | 9.1% | 16.6% | -21.8% | -47% |
NOVO-B vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -7.1% | 2.41% | -38.5% | -52% |
| Natural Gas | UNG | 10% | 27.8% | -45.4% | -28% |
| Gold | GLD | 1.6% | 12.1% | -59.9% | -95% |
| Silver | SLV | 4.4% | 7.5% | -49.2% | -71% |
| Copper | CPER | 6.8% | 16.5% | -44.4% | -54% |
NOVO-B vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 4.1% | 16.8% | -28.2% | -42% |
| iShares High Yield Corp. Bond | HYG | 5.2% | 17.4% | -33.3% | -55% |